Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

ARNA 4.63 -0.14 (-2.94%)
price chart
Notable Movers: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), EnteroMedics ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported that an article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin entitled, �Early Weight Loss While on Lorcaserin, Diet, and Exercise as a Predictor of Week 52 Weight-Loss ...
Special News: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Exelixis, Inc ...  Market News Call
Abnormal Stocks' Move- The Goodyear Tire & Rubber (NASDAQ:GT ...  eMarketsDaily
Related articles »  
Arena Pharmaceuticals Inc. Still Down After CEO's Sale
"Week-over-week prescriptions are increasing. We're very excited about that. And we expect those prescriptions to continue to increase as, yet a larger salesforce, goes into the field in the next few weeks.
Eisai and Arena Pharmaceuticals Announce BELVIQ(R) (lorcaserin HCl) CIV ...
WOODCLIFF LAKE, N.J. and SAN DIEGO, July 29, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that BELVIQ(R) (lorcaserin HCl) has been nominated by the Galien Foundation and Awards Committee ...
Related articles »  
Traders Favourite: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Novavax, Inc ...
Lakeway, NY - (MARKET NEWS CALL) - 7/30/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Investor's Watch List -Kinross Gold Corporation (USA)(NYSE:KGC),Arena ...  Techsonian (press release)
Related articles »  
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Sells Marketing And Distribution ...
Dallas, Texas 07/22/2014 (ustradevoice) - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)'s wholly owned subsidiary Arena Pharmaceuticals GmbH has undertaken a marketing and supply deal for BELVIQ� with Abic Marketing Limited, the local Israel-based ...
Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ ...  Wall Street Journal
Teva's subsidiary, Abic to market Arena Pharma's Belviq in Israel  pharmabiz.com
Related articles »  
Why Arena Pharmaceuticals (ARNA) Stock Is Dropping Today
NEW YORK (TheStreet) -- Arena Pharmaceuticals (ARNA_) shares are plummeting, down -8.1% to $5.37, on Monday after CEO Jack Lief sold 223,525 shares of the company at an average price $5.85 for a total transaction of $1,307,621.25, according to an ...
Arena chief's stock sale invites criticism (ARNA)  Seeking Alpha
Arena Stock Takes A Tumble � CEO Sells Shares, Investor Confidence Falls  Bidness Etc
Related articles »  
Arena Pharmaceuticals to Host Corporate Update and Financial Results ...
SAN DIEGO, July 25, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) today announced that it will provide a corporate update and report second quarter 2014 financial results before the NASDAQ Global Select Market opens on Friday, ...
Related articles »  
Most Active Buzz: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Oi SA (NYSE ...
Lakeway, NY - (MARKET NEWS CALL) - 7/29/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Active Watch List : Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Amazon.com ...
Arena Pharmaceuticals (NASDAQ:ARNA) CEO Jack Lief sold 223,525 shares of Arena Pharmaceuticals stock in a transaction dated Tuesday, July 1st.
News Recap: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Arena ...  Market News Call
Hot Stock List: Arena Pharmaceuticals (NASDAQ:ARNA), Glu Mobile Inc ...  Crazy Joys
Related articles »  
Whats Hot Today : Micron Technology Inc. (NASDAQ:MU), Arena ...
Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced that an article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin entitled, �Early Weight Loss While on Lorcaserin, Diet, and Exercise as a Predictor of ...